All News

The opioid crisis dominated the news in this year’s annual audit of press coverage of the pharmaceutical industry. George P. Sillup and Stephen J. Porth report.

To be successful, healthcare organizations must delve into optimizing leadership skills and building a deep pipeline of executive-ready talent.

The importance of digital engagement in the biopharma industry continues to be influenced by advancements in the technology industry as well as changes in patient needs.

Using AI to revolutionize research inefficiency. 

European drug innovators ready their defense as the Commission mulls manufacturing waiver for generic competitors.

The importance of early development strategy and planning for biologic patent term extension.

Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.

Reputation Institute study finds that the reputation of pharma companies is in decline and might get worse before it gets better.

My first gathering of Pharm Exec's Editorial Advisory Board was both an honor and a learning experience-about us, the industry, and maintaining our mission to the our readers.

Click the title above to open the Pharmaceutical Executive June 2018 issue in an interactive PDF format.

In this demanding environment, yesterday’s product launch playbook can no longer be relied upon to yield the expected patient or business outcomes, writes Boris Bogdan.